Rose Duesterwald

A team of scientists from Japan appear to have pioneered a method for reversing synapse damage in an Alzheimer's disease mouse model.

Ocugen, Inc., a biotechnology company based in Malvern, Pa. recently reported to BioSpace that DSMB gave a favorable review of its Phase ½ ArMaDa clinical study of OCU410.

Shanghai's Junshi Biosciences Co. (The Company) recently announced in Biospace

Recently there has been an increasing amount of research attempting to control CRISPR gene-editing systems.

The long-awaited positive results of Annexon Inc.'s Phase 3 trial investigating ANX005 for Guillain-Barré syndrome (GBS) was presented at the PNS 2024 Annual Meeting.

On July 11th Dr. Mathew Winton went to Capitol Hill with senators and staff from both parties to discuss collaboration with the FDA regarding the pending termination of the Priority Review Voucher (PVR) program in September.

At Japan's Fujita University, researchers reported to Inside Precision Medicine that a new risk measurement may add a layer of accuracy in predicting sudden cardiac death.

Researchers at Washington University's medical school have used a new technique to study brain neurons in a lab setting, allowing them to bypass the need to rely on a brain biopsy.

Jenny, a 40-year-old nurse with Charcot-Marie-Tooth disease began her solo voyage from Hawaii with her 6-pound Maltese dog named Romeo aboard in April 2023.

It is widely known that millions of individuals are living with diseases associated with chronic inflammation.